Cargando…
Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia
BACKGROUND: Telomeres are involved in chromosomal stability, cellular immortality and tumorigenesis. Human telomerase reverse transcriptase (TERT) is essential for the maintenance of telomere DNA length. Recently, a variable tandem-repeats polymorphism, MNS16A, located in the downstream region of th...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103564/ https://www.ncbi.nlm.nih.gov/pubmed/29936725 http://dx.doi.org/10.22034/APJCP.2018.19.6.1515 |
_version_ | 1783349361523032064 |
---|---|
author | Eskandari, Ebrahim Hashemi, Mohammad Naderi, Majid Bahari, Gholamreza Safdari, Vahid Taheri, Mohsen |
author_facet | Eskandari, Ebrahim Hashemi, Mohammad Naderi, Majid Bahari, Gholamreza Safdari, Vahid Taheri, Mohsen |
author_sort | Eskandari, Ebrahim |
collection | PubMed |
description | BACKGROUND: Telomeres are involved in chromosomal stability, cellular immortality and tumorigenesis. Human telomerase reverse transcriptase (TERT) is essential for the maintenance of telomere DNA length. Recently, a variable tandem-repeats polymorphism, MNS16A, located in the downstream region of the TERT gene, was reported to have an effect on TERT expression and telomerase activity. Previous studies have linked both relative telomere length (RTL) and TERT variants with cancer. Therefore, we evaluated associations between RTL, TERT gene polymorphisms (hTERT, rs2735940 C/T and MNS16A Ins/Del) and risk of childhood acute lymphoblastic leukemia (ALL) in an Iranian population. METHODS: RTL was determined by a multiplex quantitative PCR-based method, and variants of the hTERT, rs2735940 C/T and MNS16A Ins/Del, were genotyped by amplification refractory mutation system PCR (ARMS-PCR), and PCR, respectively. RESULTS: Our results indicated that RTL was shorter in ALL patients (1.53±0.12) compared to the control group (2.04±0.19) (P=0.029). However, no associations between hTERT gene variants or haplotypes and the risk of childhood ALL were observed (P>0.05). Also hTERT polymorphisms were not associated with RTL or patient clinicopathological characteristics, including age (P=0.304), sex (P=0.061) organomegally (P=0.212) CSF involvement (P=0.966) or response to treatment (P=0.58). CONCLUSIONS: We found that telomere attrition may be related to the pathogenesis of childhood ALL, irrespective to TERT variants. |
format | Online Article Text |
id | pubmed-6103564 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | West Asia Organization for Cancer Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-61035642018-08-28 Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia Eskandari, Ebrahim Hashemi, Mohammad Naderi, Majid Bahari, Gholamreza Safdari, Vahid Taheri, Mohsen Asian Pac J Cancer Prev Research Article BACKGROUND: Telomeres are involved in chromosomal stability, cellular immortality and tumorigenesis. Human telomerase reverse transcriptase (TERT) is essential for the maintenance of telomere DNA length. Recently, a variable tandem-repeats polymorphism, MNS16A, located in the downstream region of the TERT gene, was reported to have an effect on TERT expression and telomerase activity. Previous studies have linked both relative telomere length (RTL) and TERT variants with cancer. Therefore, we evaluated associations between RTL, TERT gene polymorphisms (hTERT, rs2735940 C/T and MNS16A Ins/Del) and risk of childhood acute lymphoblastic leukemia (ALL) in an Iranian population. METHODS: RTL was determined by a multiplex quantitative PCR-based method, and variants of the hTERT, rs2735940 C/T and MNS16A Ins/Del, were genotyped by amplification refractory mutation system PCR (ARMS-PCR), and PCR, respectively. RESULTS: Our results indicated that RTL was shorter in ALL patients (1.53±0.12) compared to the control group (2.04±0.19) (P=0.029). However, no associations between hTERT gene variants or haplotypes and the risk of childhood ALL were observed (P>0.05). Also hTERT polymorphisms were not associated with RTL or patient clinicopathological characteristics, including age (P=0.304), sex (P=0.061) organomegally (P=0.212) CSF involvement (P=0.966) or response to treatment (P=0.58). CONCLUSIONS: We found that telomere attrition may be related to the pathogenesis of childhood ALL, irrespective to TERT variants. West Asia Organization for Cancer Prevention 2018 /pmc/articles/PMC6103564/ /pubmed/29936725 http://dx.doi.org/10.22034/APJCP.2018.19.6.1515 Text en Copyright: © Asian Pacific Journal of Cancer Prevention http://creativecommons.org/licenses/BY-SA/4.0 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License |
spellingShingle | Research Article Eskandari, Ebrahim Hashemi, Mohammad Naderi, Majid Bahari, Gholamreza Safdari, Vahid Taheri, Mohsen Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia |
title | Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia |
title_full | Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia |
title_fullStr | Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia |
title_full_unstemmed | Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia |
title_short | Leukocyte Telomere Length Shortening, hTERT Genetic Polymorphisms and Risk of Childhood Acute Lymphoblastic Leukemia |
title_sort | leukocyte telomere length shortening, htert genetic polymorphisms and risk of childhood acute lymphoblastic leukemia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103564/ https://www.ncbi.nlm.nih.gov/pubmed/29936725 http://dx.doi.org/10.22034/APJCP.2018.19.6.1515 |
work_keys_str_mv | AT eskandariebrahim leukocytetelomerelengthshorteninghtertgeneticpolymorphismsandriskofchildhoodacutelymphoblasticleukemia AT hashemimohammad leukocytetelomerelengthshorteninghtertgeneticpolymorphismsandriskofchildhoodacutelymphoblasticleukemia AT naderimajid leukocytetelomerelengthshorteninghtertgeneticpolymorphismsandriskofchildhoodacutelymphoblasticleukemia AT baharigholamreza leukocytetelomerelengthshorteninghtertgeneticpolymorphismsandriskofchildhoodacutelymphoblasticleukemia AT safdarivahid leukocytetelomerelengthshorteninghtertgeneticpolymorphismsandriskofchildhoodacutelymphoblasticleukemia AT taherimohsen leukocytetelomerelengthshorteninghtertgeneticpolymorphismsandriskofchildhoodacutelymphoblasticleukemia |